Raxibacumab, officially designated as PAmAb ABthrax, signifies a unique therapeutic approach for the infection. This monoclonal protein, created by scientists, specifically targets the protective component https://raxibacumab-neutralizati355917.mpeblog.com/77210635/raxibacumab-a-thorough-investigation-into-the-p-antima-ab-disease